This bill amends Section 2-309 of the Oklahoma Statutes regarding electronic prescriptions for controlled dangerous substances. It mandates that electronic prescriptions shall be utilized for compounded prescriptions, compounded infusion prescriptions, and prescriptions issued under approved research protocols, replacing the previous language that stated they may be used in these circumstances. Additionally, the bill clarifies that no controlled dangerous substance in Schedule II can be dispensed without an electronic prescription, with specific exceptions outlined for various practitioners and situations, such as temporary technological failures or direct dispensing by practitioners.

The bill also establishes requirements for practitioners regarding the use and security of official prescription forms, including the need for registration with the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control. It specifies that practitioners must document any exceptions to the electronic prescription requirement in the patient's health record and outlines the responsibilities of registered practitioners in maintaining the security of prescription forms. The act is set to take effect on November 1, 2026.